Psilocybin-Assisted Therapy

A novel treatment that uses Psilocybin in combination with psychotherapy to treat certain mental health and substance use challenges.

What is Psilocybin-Assisted Therapy?

Psilocybin-Assisted Therapy combines regulated doses of Psilocybin (the psychoactive ingredient in some mushrooms) with psychotherapy to enhance the therapeutic process. Research and ongoing studies have shown that Psilocybin has promising therapeutic effects and could be a potential treatment for those with treatment-resistant mental health conditions. 

Psilocybin-Assisted Therapy is not currently an approved treatment and can only be accessed through FDA approved clinical trials. To learn more, book a call with our clinical trials team.

What does it treat?

Psilocybin-Assisted Therapy is currently being investigated for the treatment of a number of mental health conditions: 

  • Addiction
  • Depression & Anxiety in patients with cancer
  • Depression & Anxiety in patients at the end of their life (terminally ill) 
  • Major Depressive Disorder (MDD) 
  • Obsessive-Compulsive Disorder (OCD)
  • Post-Traumatic Stress Disorder (PTSD) 
  • Eating Disorders

In the event of an emergency, it’s crucial to seek help as soon as possible. The National Suicide Prevention Lifeline, also known as the 988 Suicide & Crisis Lifeline, is available 24/7 to provide support and resources.

You can access this service by dialing 988 or by calling 1-800-273-8255.

In the case of an immediate danger to yourself or others, calling 911 should be your first course of action.

How Does It Work?

Neuroimaging studies have shown that during a psilocybin journey, there’s a lot of neural connectivity among areas of the brain that usually don’t talk to one another. This “rewiring of the brain”, also known as neuroplasticity, and the altered consciousness that an individual experiences during treatment may result in lasting benefits. 

Psilocybin can also positively alter an individual’s perception of themselves and the world around them, which is linked to changes in mood and behaviours. Studies have shown these changes last longer than the effects of the drug. This treatment could provide patients an alternative to daily medications.



Psychedelics are an emerging area of medicine. Information on this page is presented for educational purposes only and is not an exhaustive summary of the current state of research relative to psychedelic treatments, their reliability, contraindications, risks, side effects, or other pertinent information. Other than Spravato,® a form of esketamine, psychedelic medications have not been approved by Health Canada or the Food and Drug Administration for any mental health indication. Please refer to our Educational and Opinion Disclaimer.


Stay up to date by subscribing to the Numinus Newsletter.
By signing up you consent to the Privacy Policy & Terms of Use.
Call us toll-free 1-833-NUMINUS (686-4687)
crosschevron-down linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram